Diabetes is currently recognized as the world's three major human diseases, its threat to health after cancer and cardiovascular disease. According to a recent survey released by the Department of Health, about one in every ten Taiwanese people suffers from diabetes, of which men are more serious than men aged 65 or above, and one in every three pulls a warning.
In the past, there have been studies confirmed that Ganoderma has hypoglycemic effect, and now, from the Chinese Academy of Agricultural Sciences, Jilin Institute of Research results, once again for Ganoderma can regulate blood sugar and blood lipids proved.
Researchers to streptozotocin destruction of mouse islet cells, the establishment of similar human type 2 diabetes experimental model, and then were randomly divided into four groups: one group did not give any treatment, as the diabetic control group; the other two groups were given low dose (50mg / Kg) and high dose (150 mg / kg) of Ganoderma lucidum polysaccharide extract G1-PS; and a group of patients with diabetes clinical medication glibenclamide (blood glucose level, 4mg / kg) for treatment. Finally, set up a group of normal mice, as the normal control group.
After 28 days of treatment, compared with those who did not receive any treatment of diabetic rats, two groups of Ganoderma lucidum G1-PS diabetic rats, the weight and serum insulin concentrations were significantly increased, fasting blood glucose was significantly reduced, blood lipid is also good (LDL-C, the so-called "bad cholesterol") were significantly decreased, high-density lipoprotein cholesterol (HDL-C, the so-called "good cholesterol"), triglyceride and low-density lipoprotein cholesterol ") Is significantly increased.
Compared with the western medicine group, the performance of low dose and high dose Ganoderma lucidum was better in the promotion of serum insulin concentration and lipid regulation. As for the changes in blood glucose, although the treatment of the first 7 days and 14 days, high-dose Ganoderma group blood sugar is still higher than the Western medicine group, but to the 21st day, high-dose Ganoderma group blood sugar has approached the Western medicine group; High doses of Ganoderma lucidum group of blood sugar has been lower than the Western medicine group, and normal mice blood sugar closer.
Low-dose Ganoderma group at the end of the test blood glucose data, although not as high as the dose of Ganoderma lucidum so beautiful, but from the 28-day decline, it should only be a matter of time. Therefore, when the front line to look, Ganoderma lucidum polysaccharides do not lose blood sugar effect - as long as enough or enough time, but also with the role of hypolipidemic.
In addition, the study also conducted an acute toxicological test, over 48 hours of 5000 mg / kg of Ganoderma lucidum G1-PS, the results did not result in any abnormal appearance of the mouse (including easy to be angered, Shortness of breath, abnormal limb movement, whole body stiffness) or death, which means that Ganoderma lucidum of ganoderma supplier polysaccharide has a high degree of safety, and Western medicine has a toxic side effects.
The above study shows that Ganoderma lucidum polysaccharides for diabetes-related symptoms, including weight loss, serum insulin concentration is too low, there are too high blood sugar and blood lipids, have improved results. At the same time to improve blood sugar and blood lipids for diabetes control is very important, because diabetes is easy to merge with hyperlipidemia, and high blood lipids will not only accelerate the deterioration of blood sugar, but also lead to stroke, myocardial infarction, kidney disease and other more serious problems. For such a complex disease, Ganoderma lucidum polysaccharide "together to solve" the function is obviously very cost-effective.